Publicaciones en colaboración con investigadores/as de Fundación Renal Iñigo Alvarez de Toledo (12)

2023

  1. Erratum to “Recommendations for living donor kidney transplantation” (NEFROLOGIA (English Edition) (2022) 42(S2) (1–4), (S2013251422001444), (10.1016/j.nefroe.2022.01.009))

    Nefrologia

  2. Erratum to “Recommendations for living donor kidney transplantation” (NEFROLOGÍA (2022) 42(S2) (129–132), (S0211699522000133), (10.1016/j.nefro.2022.01.007))

    Nefrologia

2022

  1. Recommendations for living donor kidney transplantation

    Nefrologia, Vol. 42, pp. 5-132

  2. Validation of the inverse method for the determination of the access flow with thermodilution

    Nefrologia, Vol. 42, Núm. 1, pp. 56-64

2020

  1. Intra-method variability in the measurements of vascular access using the thermodilution technique: An enemy in follow-up programs?

    Enfermeria Nefrologica, Vol. 23, Núm. 4, pp. 353-360

2015

  1. Activation of the ALK-5 pathway is not per se sufficient for the antiproliferative effect of TGF-β1 on renal tubule epithelial cells

    Cellular Physiology and Biochemistry, Vol. 37, Núm. 4, pp. 1231-1239

2013

  1. Increased urinary excretion of albumin, hemopexin, transferrin and VDBP correlates with chronic sensitization to gentamicin nephrotoxicity in rats

    Toxicology, Vol. 304, pp. 83-91

  2. Membrane and soluble forms of endoglin in preeclampsia

    Current Molecular Medicine, Vol. 13, Núm. 8, pp. 1345-1357

  3. TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1832, Núm. 10, pp. 1744-1755

2012

  1. Role of TGF-β in chronic kidney disease: An integration of tubular, glomerular and vascular effects

    Cell and Tissue Research, Vol. 347, Núm. 1, pp. 141-154

  2. Subcellular targets of cisplatin cytotoxicity: An integrated view

    Pharmacology and Therapeutics, Vol. 136, Núm. 1, pp. 35-55

2010

  1. Sub-nephrotoxic doses of gentamicin predispose animals to developing acute kidney injury and to excrete ganglioside M2 activator protein

    Kidney International, Vol. 78, Núm. 10, pp. 1006-1015